India, March 13 -- Shares of MeiraGTx Holdings plc (MGTX) jumped 17% on Thursday morning after the company announced a broad strategic collaboration with Hologen Limited to manufacture AAV-GAD and other locally delivered CNS genetic medicines.
MGTX is currently trading at $7.50, up $1.09 or 17.00%, on the Nasdaq. The stock opened its trading at $7.73 after closing Wednesday at $6.41. The stock has traded between $3.85 and $8.49 in the past 52-week period.
MeiraGTx will receive $200 million in upfront cash at closing and MeiraGTx and Hologen are forming a joint venture, called Hologen Neuro AI Ltd.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
In addition to the $200 million upfront payment to Meira...